ERBB2 and gastric cancer: Firstly, we could confirm the presence of a high level of concordance in HER2 status between primary GC and corresponding lymph node metastases (90.74%), as it was previously shown in studies on metachronous metastases (87.5%–94.9%) [19,23,24].